Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.94
Delayed Data
As of May 29
 -0.10 / -4.90%
Today’s Change
1.53
Today|||52-Week Range
4.20
+5.43%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 2.60, with a high estimate of 2.60 and a low estimate of 2.60. The median estimate represents a +34.02% increase from the last price of 1.94.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$6.4M
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 0.00%
 
 
 
 
 
 

Sales

Growthquarterly 45.72%
 
 
 
 
 
 
Growthannually 114.64%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account